The MAPLE Study is a clinical research opportunity for adult patients who have experienced an episode of worsening within the past 2 years.
The purpose of the MAPLE study is to evaluate the safety and efficacy of a study drug in adults with CIDP, including whether it can reduce disease progression and maintain nerve function in individuals with CIDP.
Be 18 years of age or older
Have a confirmed diagnosis of CIDP including:
Typical, multifocal, or motor CIDP
Have clinical records documenting active disease, defined as evidence of at least 1 clinically meaningful deterioration within 2 years prior to screening.
Be on a maintenance regimen of IVIg, SCIg, or oral corticosteroids that has remained stable for 8 weeks prior to screening.
Sensory, focal, or distal CIDP variants
Other eligibility criteria apply and will be evaluated by a principal investigator.
About the MAPLE Study
The MAPLE Study aims to assess whether a study drug can reduce disease progression and maintain nerve function in individuals with CIDP.
The study includes an optional open-label study after the randomized placebo-controlled part of the study, so all participants have the opportunity to receive the study drug following the conclusion of the treatment period.
Be randomized to receive either the study drug or placebo.
Visit the research site up to 20 times during the study which lasts around 2.5 years.
The study drug or placebo is delivered three times during the treatment period and an additional three times if participating in the open-label period.
Next Steps
If you have a patient who might be interested and potentially eligible for this study you can:
Complete the "Contact PatientWing" form below. We’ll contact you and discuss how your patient can get involved.
Share this study directly with your patient so they can apply on their own. Provide them with this website so they can read about the study and fill out a questionnaire.
Contact PatientWing
If you have a patient who may be eligible, we would love to speak with you!
Phone
213-459-2979Please submit the information below so our team can reach out. There is no obligation to you or your patient by submitting this form.
